Sclerostin: An osteocyte-expressed BMP antagonist the inhibits bone formation by mature osteoblasts.

被引：0
|
作者：
Van Bezooijen, RL
Winkler, D
Hayes, T
Karperien, M
Visser, A
van der Wee-Pals, L
Hamersma, H
Papapoulos, SE
Latham, JA
Lowik, CWG
机构：
[1] Florida Pk, Roodeport, South Africa
[2] Celltech Inc, Bothell, WA USA
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1077
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
    van Bezooijen, RL
    Roelen, BAJ
    Visser, A
    van der Wee-Pals, L
    de Wilt, E
    Karperien, M
    Hamersma, H
    Papapoulos, SE
    ten Dijke, P
    Löwik, CWGM
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (06): : 805 - 814
  • [2] SCLEROSTIN IS AN OSTEOCYTE-EXPRESSED NEGATIVE REGULATOR OF BONE FORMATION, BUT NOT A CLASSICAL BMP ANTAGONIST
    Lowik, C.
    Ten Dijke, P.
    Van Bezooijen, R.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S22 - S22
  • [3] Sclerostin is an osteocyte-expressed negative regulator of bone formation.
    Lowik, C
    ten Dijke, P
    van Bezooijen, R
    BONE, 2003, 33 (05) : S19 - S19
  • [4] SOST, a BMP antagonist expressed in mature osteoblasts, regulates bone formation.
    Sutherland, MSK
    Geoghegan, J
    Winkler, DG
    Hayes, T
    Ursino, RJ
    Staehling-Hampton, K
    Zhao, L
    Latham, JA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S322 - S322
  • [5] Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
    Winkler, DG
    Sutherland, MK
    Geoghegan, JC
    Yu, CP
    Hayes, T
    Skonier, JE
    Shpektor, D
    Jonas, M
    Kovacevich, BR
    Staehling-Hampton, K
    Appleby, M
    Brunkow, ME
    Latham, JA
    EMBO JOURNAL, 2003, 22 (23): : 6267 - 6276
  • [6] Increasing levels of serum sclerostin, an osteocyte-expressed negative regulator of bone formation, are associated with atherosclerotic disease in type 2 diabetes
    Morales, S.
    Garcia-Fontana, B.
    Garcia-Martin, A.
    Rozas-Moreno, P.
    Garcia-Salcedo, J. A.
    Reyes-Garcia, R.
    Munoz-Torres, M.
    BONE, 2012, 50 : S175 - S175
  • [7] BMP-antagonist sclerostin is expressed in mineralized bone and blocks BMP-induced bone formation in vitro.
    van Bezooijen, RL
    Karperien, M
    Visser, A
    Hamersma, H
    Winkler, D
    Hayes, T
    Skonier, J
    Staehling-Hampton, K
    Latham, JA
    Papapoulos, SE
    Lowik, CWG
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S163 - S163
  • [8] Sclerostin inhibits BMP-stimulated bone formation by antagonizing Wnt signaling
    van Bezooijen, RL
    Visser, A
    van der Horst, G
    Karperien, M
    Papaloulos, SE
    ten Dijke, P
    Löwik, CWGM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S9 - S9
  • [9] Osteocyte-derived sclerostin inhibits bone formation:: Its role in bone morphogenetic protein and Wnt signaling
    ten Dijke, Peter
    Krause, Carola
    de Gorter, David J. J.
    Loewik, Clemens W. G. M.
    van Bezooijen, Rutger L.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A : 31 - 35
  • [10] SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
    Bezooijen, RL
    ten Dijke, P
    Papapoulos, SE
    Löwik, CWGM
    CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) : 319 - 327
12345